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Background.— In the elderly, cognitive impairment is associated with loss of independence and
may be predictive of mortality.MMSE; Aims.— Our aim was to determine if cognitive impairment correlated to poor prognosis in an
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Elderly
elderly (> 70 years) hospitalized population with cardiovascular diseases. Our other goal was to
explore other factors that might inﬂuence mortality risk. Better understanding of these factors
should help practitioners select tools to assess these patients and prevent the occurrence of
adverse outcomes.
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Methods.— During 4 years of follow-up, medical events and all-cause mortality were reported
in 331 patients aged above 70 years, as well as clinical and biological variables and Mini Mental
State Examination scores.
Results.— Patients with cognitive impairment were older and had a lower body mass index than
patients without cognitive impairment (P = 0.023). When all factors were forced into the Cox
model, cognitive impairment remained an independent predictor of mortality (P < 0.001). High
plasma glucose, low body mass index and low plasma albumin were associated with overall
mortality, independent of cognitive impairment.
Conclusion.— In elderly inpatients aged above 70 years with cardiovascular diseases, cognitive
impairment and malnutrition are associated, and both are predictors of all-cause mortality.
Early nutrition programmes may help to delay mortality, as well as screening the impairment
of neuropsychological functioning using the total Mini Mental State Examination score.
© 2013 Elsevier Masson SAS. All rights reserved.
MOTS CLÉS
Troubles cognitifs ;
MMSE ;
Mortalité ;
Facteurs de risques
cardiovasculaire ;
Vieillissement ;
IMC
Résumé
Contexte.— Chez les patients âgés, les troubles cognitifs sont accompagnés d’une perte
d’indépendance qui pourrait conduire à la mortalité.
Objectifs.— L’objectif de cette étude était de déterminer, de fac¸on globale, si les troubles
cognitifs sont corrélés à un pronostic plus mauvais chez les sujets âgés (> 70 ans) hospitalisés,
ayant des maladies cardiovasculaires. L’autre objectif était d’explorer les différents facteurs
qui pourraient modiﬁer le risque de mortalité. Une meilleure compréhension de ces facteurs
pourrait aider les praticiens dans leurs pratiques de prévention.
Méthodes.— Pendant quatre ans de suivi, les événements intercurrents et les causes de mor-
talité ont été rapportés chez 331 patients âgés plus de 70 ans.
Résultats.— Les analyses statistiques ont montré que les troubles cognitifs représentent un
facteur de risque indépendant de la mortalité. Les patients présentant des troubles cognitifs
étaient les plus âgés, avaient un index de masse corporelle plus bas que les autres (p = 0,023).
Quand les autres facteurs de risque étaient introduits dans le modèle statistique, les troubles
cognitifs demeuraient un facteur de risque indépendant prédictif de la mortalité (p < 0,001).
L’hyperglycémie, le faible IMC et l’hypoalbuminémie étaient signiﬁcativement associés à la
mortalité indépendamment des troubles cognitifs.
Conclusion.— Chez les sujets âgés (> 70 ans) hospitalisés ayant des maladies cardiovasculaires,
les troubles cognitifs et la dénutrition sont associés et tous les deux sont prédictifs de la
mortalité. Des programmes de nutrition adaptés pourraient contribuer à un meilleur pronostic.
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Introduction
Impairment of cognitive functions is a common disorder in
older people. Cognitive impairment (CI) is associated with
decreased memory function and/or other neuropsycholo-
gical deﬁcits, such as impairment of executive functions,
apraxia, agnosia or aphasia. CI represents a major risk factor
associated with loss of personal independence and, ﬁnally,
with the development of dementia, especially Alzheimer’s
disease, which is the most common form of neurodegen-
erative dementia in the elderly [1]. Recent studies on CI,
particularly those involving Mini Mental State Examination
(MMSE) determinations, have shown the increasing preva-
lence of dementia with advancing age, affecting around 7%
of individuals aged above 65 years and 30% of those aged
above 80 years [1—3]. Thus, patients with CI could exhibit
difﬁculties in completing instrumental activities of daily liv-
ing, such as managing ﬁnances, organizing medications and
food preparation [4]. Therefore, a better understanding of
the role of multiple factors (as clinical markers) associated
with the onset and progression of cognitive decline with
advancing age would be useful in the development of new
c
ps droits réservés.
revention methods. Each year, as an increase in the aver-
ge life span is observed, the need to perform such studies in
he elderly becomes urgent, not only in the ‘young elderly’,
ut also in those aged above 70 years [5].
Neuropsychological evaluations and mostly novel neu-
oimaging methodologies suggest that major modiﬁcations
ithin the nervous tissue itself (mainly the cerebral white
atter) may be at the origin of CI in the elderly [6]. However,
here are many arguments suggesting that vascular damage
ightmake a substantial additional contribution [7]. In addi-
ion, metabolic and nutritional modiﬁcations occur in older
eople and may interact with vascular factors; both may
ontribute to overall risk. Finally, increased arterial stiffness
ay be deleterious for the cardiovascular system, especially
n the presence of inﬂammation or malnutrition [8]. On the
ther hand, in the elderly population, only type 2 diabetes
ellitus remains an important risk factor, as other cardio-
ascular risk factors do not have the same effect in adults
r older people [9].Although the population proﬁles of industrialized
ountries show dramatic increases in the number of elderly
eople, few studies have focused on CI in very old age
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10—12]. Recently, Strandberg et al. reported that a low
MSE score was predictive of mortality in home-dwelling
atients with cardiovascular disease (CVD) aged 75 years or
bove [13]. However, this study did not explore hospital-
zed patients, despite them being the most vulnerable and
ependent patients and also the most likely to have multiple
isk factors for mortality.
Our ﬁrst working hypothesis was that, in elderly hospi-
alized subjects aged above 70 years and presenting CVD,
I studied prospectively should also be a good predictor of
verall and cardiovascular mortality risk. In addition, we
nvestigated the factors signiﬁcantly correlated to CI and all-
ause mortality, to suggest new therapeutic and prevention
ethods, particularly in patients presenting CVDs.
ethods
tudy cohort
nclusion criteria were as follows: age above 70 years; his-
ory of CVD (deﬁned in this study as presence or history of
rterial hypertension, coronary heart disease, cerebrovas-
ular disease, history of clinically assessed heart failure or
ny vascular event of the arteries of the upper or lower
imbs, the thoracic or abdominal aorta or the renal arter-
es); MMSE greater than 15 out of 30 (to make sure the
atient could give informed consent to participate in the
tudy), with no severe visual or hearing impairment, absence
f fatal disease and life expectancy less than 1 month.
atients with cachexia (body mass index [BMI] < 17 kg/m2)
nd/or advanced cancer and/or renal failure (plasma crea-
inine > 250mol/L) were not included.
From May 2000 to November 2001, 331 consecu-
ive patients (86 men and 245 women) with a mean
ge± standard deviation of 87± 7 years (range: 72—104
ears), hospitalized in the geriatric departments of two Île-
e-France (Paris suburbs) hospitals (Charles Foix and Emile
oux), were included in the PRonostic cardiovasculaire et
ptimisation Thérapeutique En GERiatrie (PROTEGER) study.
ll patients had CVD; 17% had a history of dyslipidaemia,
1% diabetes, 75% arterial hypertension, 78% coronary heart
isease, 22% heart failure, 28% cerebral infarction and 28%
eripheral artery disease.
The PROTEGER study was approved by the Committee for
he Protection of Human Subjects in Biomedical Research
f the Saint-Germain Hospital in Île-de-France. Written
nformed consent was obtained from all participants after
elevant information was given to them and/or to their rela-
ives. Variables that are important for the present analysis
re presented here.
ocial and clinical characteristics of patients
nformation compiled from the questionnaire ﬁlled out
t inclusion comprised: sex; age; weight; height; per-
onal history of cardiovascular event; presence of diabetes
ellitus, dyslipidaemia or arterial hypertension; smoking
abits; and previous diseases. The reason for hospitalization
nd total MMSE score were registered once, at inclusion,
n haemodynamically-stabilized conditions. The education
evel (1 indicates primary school; 2, college degree; 3,
a
a
c
dK. Farid et al.
achelor degree; and 4, university degree) was also reg-
stered. In some subjects, such information was provided
y relatives and/or recorded from the most recent previous
ospitalization.
ollow-up procedures
ollow-up started from the baseline examination and lasted
ntil April 2004. Among the 331 participants in the present
tudy, three (1%) were lost to follow-up. Information was
btained from the patients themselves, from their relatives
r from general practitioners. Interim telephone and clinic
ontacts were used to assess all the hospitalizations, out-
atient cardiovascular diagnoses and overall mortality. In
he case of hospitalization, discharge reports from medical
pecialists were obtained. Fatal and non-fatal cardiovascu-
ar events and all-cause mortality were reported. Follow-up
ime was deﬁned as the time from the baseline visit to April
004 for those who survived, to the last contact date for
hose who were lost to follow-up or to death for the others.
ini Mental State Examination evaluation
he MMSE, the most commonly administered psychometric
creening assessment of cognitive functioning, is a simple
nd rapid test that may be done by any clinician to evaluate
lobal cognitive functions, especially in primary care [14].
he MMSE has been reported to be a reliable and repro-
ucible method, measuring ﬁve areas of cognition labelled
s ‘orientation’, ‘registration’, ‘attention and calculation’,
recall’, and ‘language’ [14,15]. A lower MMSE score has
een previously reported to predict a higher mortality in
ubjects with neurological diseases [16] and with CVD [13].
cores of less than 23—24 points out of 30 have been con-
idered to indicate CI. MMSE scores have been previously
eported to be affected by age, education and cultural back-
round, but less by sex [17]. There are no standard cut-offs
or the MMSE with regard to education, as prior studies have
uggested different cut-offs [18,19]. In a French population,
MSE was adjusted to educational level and Kalafat et al.
eﬁned the pathological cut-off scores as 20—21 in low edu-
ational groups and 24 in high educational groups [20]. In
his study, MMSE was adjusted to educational level and sig-
iﬁcant CI was deﬁned as MMSE less than 20 in subjects with
rimary education (level 1) and less than 24 in subjects with
igher education (levels 2, 3 and 4) [19].
ssessment of haemodynamic and biological
ariables
aemodynamic measurements were performed in the morn-
ng (8.00—10.00 a.m.). Brachial blood pressure (BP) was
easured after 15 minutes’ rest, using the semiautomatic
scillometric device (Dynamap-Kontron, Paris, France).
ortic pulse wave velocity was determined using the foot-to-
oot method in only 283 patients. Venous blood samples were
btained in patients after an overnight fast. Plasma was sep-
rated without delay at 4 ◦C in a refrigerated centrifuge
nd stored at 4 ◦C until analysis. Total cholesterol, trigly-
erides, high-density lipoprotein (HDL) cholesterol, low-
ensity lipoprotein (LDL) cholesterol, plasma creatinine,
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Table 1 Models predicting all-cause mortality by Cox regression analysis.
 Hazard ratioa 95% CI P
Model Ab: Chi2 = 21.2; P < 0.001
Cognitive impairment (1, 0) 0.71 2.03 1.38—2.98 < 0.001
Model Bc: Chi2 = 54.1; P < 0.001
Cognitive impairment (1, 0) 0.71 2.04 1.32—3.15 0.001
Albumin (g/L) —0.47 0.63 0.49—0.80 < 0.001
Glucose (mmol/L) 0.29 1.33 1.11—1.61 0.003
BMI (kg/m2) —0.38 0.68 0.52—0.89 0.004
HDL cholesterol (mmol/L) —0.32 0.72 0.56—0.93 0.011
CI: conﬁdence interval; BMI: body mass index; HDL: high-density lipoprotein.
a Hazard ratios were calculated for a 1 standard deviation increase in all quantitative variables and the presence of qualitative variables
against the absence.
b Model A = age, male sex, hospital location and cognitive impairment
c Model B =model A + education level, residence condition, systolic and diastolic blood pressures, heart rate, smoking, antidepressive
therapy, total cholesterol and triglycerides. Age, male sex and hospital location were forced in both models. Only signiﬁcant results are
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plasma albumin and orosomucoid concentrations were mea-
sured as previously described [8].
Statistical analysis
Social, clinical and biological variables, as well as previous
cardiovascular events and cardiovascular mortality and all-
cause mortality, were compared between subjects with or
without CI, using Student’s t test for quantitative variables
and the Chi2 test for qualitative variables. Logistic regres-
sion models were used to investigate determinants of CI
with the stepwise method. The independent association of
all-cause mortality with CI was studied by stepwise Cox
regression analysis in all subjects and subjects without CI,
after adjustment for confounders. Statistical analysis was
performed using SAS software, version 9.1 (SAS institute,
Cary, NC, USA). A P value < 0.05 was considered statistically
signiﬁcant. In Table 1, only signiﬁcant results have been
mentioned in model B.
Results
General characteristics of the population
The population was composed of 331 patients (86 men, 245
women) with a mean age of 87± 7 years. All patients had
a past history of CVD but the reasons for their hospital-
ization were as follows: a cardiovascular event (19% of all
patients); various physical injuries mostly due to falls (36%);
unspeciﬁed neuropsychological problems (14%); social rea-
sons (mainly a bridge to a nursing home) (10%); various
infections (10%); and other miscellaneous causes (11%). A
total of 138 patients (42%) had CI and 191 (58%) had no CI.
The mean total MMSE score was 22.2± 5.2. After a mean
follow-up of 380± 196 days (extremes: 50—848 days), 110
subjects (33%) had died.Table 2 compares the clinical, biological and cardiovas-
cular haemodynamic variables, as well as the medication
of CI versus non-CI subjects at the end of follow-up. CI
patients were older (P = 0.017), although the prevalence of
f
B
c
pI with aging was signiﬁcant in men (n = 86; P = 0.04) but
ot in women (n = 244; P = 0.29). CI patients had a lower BMI
P = 0.023) than non-CI patients, an indicator of malnutri-
ion. In contrast with non-CI patients, CI subjects usually
ived in an assisted-living community (nursing home) before
ospitalization (P = 0.050) and tended to have a low mood as
hey consumed more antidepressive drugs (P = 0.092).
All-cause mortality was signiﬁcantly higher in the CI group
ompared with in non-CI patients (P < 0.001). However, this
ajor ﬁnding was not observed for cardiovascular mortality
Figs. 1 and 2).
ardiovascular risk factors and cognitive
mpairment
logistic stepwise regression was conducted, including the
ovariables age, male sex, location, education rate, res-
dence condition, smoking, antidepressive therapy, BMI,
ystolic and diastolic BP, heart rate, plasma glucose, total
holesterol, triglycerides, HDL cholesterol and albumin,
ith the ﬁrst three variables forced in model A. CI patients
ad a very high degree of statistical link to low BMI
P = 0.009) and high consumption of antidepressive drugs
P = 0.017).
Traditional cardiovascular haemodynamic variables, such
s carotid systolic BP, carotid diastolic BP, carotid pulse pres-
ure, pulse wave velocity, carotid intima-media thickness
nd carotid calciﬁcation, were not signiﬁcantly different in
he presence or absence of CI (Table 2).
odels predicting all-cause mortality by Cox
egression analysis
ox regression analysis (Table 1) showed that CI was a pre-
ictor of mortality, independent of age, sex and residence
ondition at inclusion (model A). In addition to the three
actors in model A, systolic and diastolic BP, heart rate,
MI, smoking, antidepressive therapy, plasma glucose, total
holesterol, HDL cholesterol, triglycerides and albumin were
ut in model B. The presence of CI remained a major and
192 K. Farid et al.
Table 2 Characteristics of subjects with or without cognitive impairment.
All subjects
(n = 331)
No CI
(n = 191)
CI
(n = 138)
P
Main patient characteristics
Age (years) 86.8± 6.9 86.0± 7.2 87.9± 6.4 0.017
Male sex 86 (26.0) 50 (26.2) 35 (26.4) 0.868
Body mass index (kg/m2) 27.2± 5.7 27.8± 6.0 26.4± 5.1 0.023
Smokinga 87 (26.4) 57 (29.8) 29 (21.2) 0.078
Education levelb 123 (37.2) 64 (33.5) 57 (41.3) 0.148
Residence conditionc 288 (87.5) 173 (90.6) 115 (83.3) 0.050
Antidepressive therapy 115 (34.7) 59 (30.9) 55 (39.9) 0.092
Haemodynamic measurements
Systolic BP (mmHg) 131.7± 20.8 132.5± 22.0 130.9± 21.7 0.504
Diastolic BP (mmHg) 65.3± 11.6 65.6± 11.3 65.1± 12.0 0.654
Carotid systolic BP (mmHg) 124.5± 20.3 124.7± 20.0 124.7± 20.5 0.993
Carotid diastolic BP (mmHg) 71.5± 10.7 71.7± 10.0 71.6± 11.6 0.993
Heart rate (bpm) 70.2± 10.1 70.3± 9.9 70.3± 10.5 0.978
Pulse wave velocity (m/s) 14.4± 3.6 14.4± 3.6 14.5± 3.7 0.938
Left carotid IMT (m) 840.9± 144.3 828.4± 133.0 856.7± 158.3 0.110
Carotid calciﬁcation 290 (88.7) 166 (87.8) 124 (89.9) 0.568
Previous cardiovascular events 108 (32.6) 65 (34.0) 42 (30.4) 0.492
Cardiovascular risk factorsd
Glucose (mmol/L) 5.94± 2.31 5.84± 2.04 6.04± 2.65 0.470
Total cholesterol (mmol/L) 5.27± 1.20 5.37± 1.22 5.15± 1.17 0.117
HDL cholesterol (mmol/L) 1.11± 0.31 1.10± 0.32 1.14± 0.30 0.278
LDL cholesterol (mmol/L) 3.42± 1.00 3.51± 1.03 3.30± 0.95 0.066
Triglycerides (mmol/L) 1.57± 0.89 1.60± 0.69 1.53± 1.11 0.515
Creatinine (mol/L) 80.5± 32.2 79.9± 29.4 81.1± 35.7 0.822
Albumin (g/L) 34.4± 4.9 34.8± 4.6 33.9± 5.3 0.118
hs-CRP (mg/L) 22.8± 40.0 22.3± 44.4 23.4± 33.3 0.813
Orosomucoid (g/L) 1.21± 0.40 1.20± 0.39 1.21± 0.42 0.838
Cardiovascular mortality 35 (13.7) 16 (8.4) 18 (13.0) 0.170
All-cause mortality 110 (33.2) 49 (25.7) 60 (43.5) < 0.001
Data are mean± standard deviation or number (%). BP: blood pressure; bpm: beats per minute; CI: cognitive impairment; HDL:
high-density lipoprotein; hs-CRP: high-sensitive C-reactive protein; IMT: intima-media thickness; LDL: low-density lipoprotein.
a Smoking indicates subjects currently smoke or have a history of smoking.
b Education level indicates prevalence of subjects obtaining education higher than primary school (levels 2, 3 and 4).
c Residence condition was classiﬁed as living at home with or without family (1) or living in a nursing home (0).
d Previous cardiovascular events were deﬁned as a history of myocardial infarction or stroke.
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or potential confounders in models A and B.
All-cause mortality risk was associated with several
ndependent variables: metabolic factors, with low HDL
holesterol (P = 0.011) and high plasma glucose concen-
rations (P = 0.003); and nutritional factors, with low BMI
P = 0.004) and low plasma albumin (P < 0.001) (Table 1).
owever, it is worth noting that whereas metabolic factors
nly directly inﬂuence overall mortality, nutritional fac-
ors, such as BMI, are also independently associated with
I (Table 2; P < 0.023).iscussion
his study shows that, in a population of frail hospi-
alized patients aged above 70 years with a history of
l
D
i
tVD, malnutrition (as deﬁned by a low BMI) and cognitive
ecline (as deﬁned by a low MMSE score) are predictors
f overall, but not cardiovascular, mortality. In addition,
here are more factors predictive of mortality than car-
iovascular factors in this population of very old subjects.
hese ﬁndings were observed even after adjustment for
otential confounders, such as age, sex and residence
ondition, as well as traditional cardiovascular risk factors
Table 2).
The importance of CI in this population can be explained.
I may interfere with the ability of patients with CVD to suc-
essfully take up new information and engage in self-care.
or example, deﬁcits in memory and attention can impair
earning ability and retention of health care information.
eﬁcits in executive functions can interfere with recogniz-
ng, interpreting and managing changes in treatment related
o CVD [21].
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Figure 1. All-cause mortality (expressed as %) was signiﬁcantly
higher in the cognitive impairment (CI) group compared with in
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tnon-CI patients (P < 0.001) but a difference was not observed for
cardiovascular (CV) mortality.
Mini Mental State Examination: limitations and
strength
MMSE has been previously reported as a predictor of func-
tional disability in the elderly [22] and as a predictor of
mortality in nonagenarian subjects [23].CI may be undetected without formal screening, sug-
gesting the need of a systematic search with a simple
method. The total MMSE score (out of 30) was registered
Figure 2. Probability of all-cause survival in subjects with or with-
out cognitive impairment (log-rank: Chi2 = 16.23; P < 0.001).
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nce in this study, at inclusion. Although the cut-off scores
f 20 (primary education) and 24 (higher level) are suf-
ciently accurate to detect patent CI, it is worth noting
hat total MMSE score is not relevant for screening speciﬁc
europsychological impairments (e.g. apraxia or agnosia)
r impairment in executive functions, or for pointing out
he nature of the neurological disease (Alzheimer’s disease,
ascular dementia, frontotemporal dementia, etc.).
alnutrition and mortality
t is well known that midlife high BMI is related with a poor
utcome. However, this is mainly observed in young car-
iovascular patients [12]. In elderly patients, malnutrition
deﬁned as low BMI and low albumin) seems to be associated
ith a high risk of mortality. Indeed, in elderly patients, BMI
s considered a marker of protein stores rather than adipos-
ty itself. Current guidelines suggest a BMI less or equal to
1 as major trigger for nutritional support [24].
Malnutrition may be associated with the previously
escribed reverse metabolic syndrome [9,25]. The transition
o a state of malnutrition, as a sign of the reverse metabolic
yndrome, confounds the use of conventional risk factors.
s previously described, whereas diabetes remains a major
isk factor, the classical role of lipids tends to disappear [9].
Malnutrition was signiﬁcantly associated with overall
ortality and linked to the presence of CI in this study
Table 2). Such results suggest the presence of a signiﬁ-
ant association between patent CI and malnutrition in frail
ospitalized cardiovascular subjects aged above 70 years.
ndeed, confusion, low mood and lower functional status as
ell as hospitalization have been reported to be associated
ith inadequate nutritional intake and loss of independence
26].
Interestingly, in our population, CI patients had a
igniﬁcantly lower BMI, suggesting that both CI and malnu-
rition may interact synergistically to the detriment of life
xpectancy in hospitalized patients. In fact, patients with
I may be unable to cook or may forget to eat or to buy
ood. Thus, prevention, screening and treatment of malnu-
rition may deserve higher priority than previously believed
n the care of the very old patients. The assessment could
e done easily by any healthcare professional, by calculating
he BMI.
Regarding prevention, nutritional prevention pro-
rammes could be developed and proposed in adulthood,
efore the risk of cognitive decline arises.
alnutrition and cognitive impairment: better
redictive factors of all-cause mortality than
ardiovascular disease
n our study of elderly hospitalized patients, even if
utritional factors and CI could interact synergistically, mal-
utrition and CI were independent risk factors of all-cause
ortality and appeared better predictive factors than CVD
Table 1).
Driver et al. [27], in their prospective cohort study of
ore than 22,000 male doctors over a 23-year follow-up,
eported an increasing rate of major CVD up to the age of
9 years. The authors also reported an increasing cumulative
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review and critique; D. Bachelier, manuscript review and
critique; P. Gilson, manuscript review and critique; A.
Teixeira, statistical analysis and manuscript review and
critique; M.E. Safar, research project conception, organiza-94
ncidence curve for major vascular disease to the age of 100
ears. Nevertheless, after adjustment for competing risks
or death, they showed a decrease in risk of major CVD in
en aged above 80 years. This may be explained by the
elective survival of patients who are more resistant to dis-
ase. As previously described by Vesin et al., Vischer et al.
nd Meaume et al. [9,28,29], our hospitalized population,
ho had a history of CVD, was composed mainly of ‘sur-
ivors’ owing to the traditional cardiovascular risk factors.
his might explain the lack of signiﬁcant association with
VD, risk factors and mortality.
The geriatric syndrome of frailty, as deﬁned by the
onsensus supported by the Interventions on Frailty Work-
ng Group [30], is recognized to have some predictive value
or adverse health outcomes in the elderly population [31].
his geriatric syndrome is considered to be a clinical syn-
rome characterized by the presence of at least three of
he ﬁve following components: weight loss; self-reported
xhaustion; weakness; slow walking speed; and low physi-
al activity. Avila-Funes et al. [32], in their French three-city
tudy, showed that CI improved the predictive value of this
perational clinical deﬁnition of frailty. In their study, the
isk of death tended to be higher in frail participants with
I than in their non-frail counterparts without CI. In our
tudy, we could hypothesise that patients with malnutri-
ion and CI could also correspond to a frail population, as
eﬁned classically and clinically [31]. This point would sup-
ly an explanatory basis for the link between malnutrition,
I and mortality, which was signiﬁcantly observed in our
tudy. Unfortunately, we cannot classify our participants
linically as frail or non-frail patients so we cannot conﬁrm
his hypothesis.
egative ﬁndings
ardiovascular disease and cognitive impairment
t is generally accepted that vascular disorders are positively
elated to CI, while in this study we considered most of the
ardiovascular risk factors, including smoking, obesity, BP,
ale sex, cholesterol and glucose, but with numerous nega-
ive P values. These negative results may suggest that their
igniﬁcant association has been lost, indicating that in the
ast period of life, vascular diseases or dysfunctions have
ess inﬂuence on CI.
ardiovascular disease, risk factors and mortality
t is well known that vascular diseases represent a high
ortality risk factor. Interestingly, in the present study,
either the traditional cardiovascular risk factors nor the
aemodynamic variables indicated in Table 2 were related
o mortality in this elderly population. Only hyperglycaemia
elated to diabetes remained a risk factor.
CVD may be related to reverse metabolic syndrome in the
lderly [9,33]. It is possible that patients with more severe
ardiovascular impairments may have died before having the
age opportunity’ of entering the study.tudy limitations
his study has several limitations. First, MMSE was the
nly test used for CI screening. Speciﬁc neuropsychological
t
B
c
cK. Farid et al.
ysfunctions (such as apraxia, agnosia, aphasia or impair-
ent in executive functions) were clinically described by
he examiner, but no speciﬁc neuropsychological assessment
ool (Trail Making Test A and B, Grober and Buschke, verbal
uency, etc.) was used. Furthermore, neither speciﬁc neu-
oimaging examinations nor analysis of cerebrospinal ﬂuid
ere performed. Thus, the cause of the CI in this population
as not determined and CI has been used for classiﬁcation
s a syndrome. In addition, the MMSE was performed only
nce and, unfortunately, was not repeated. However, it was
erformed in stabilized conditions. In addition, the same
xaminer collected the scores. Taken together, all this infor-
ation reduces the risk of variability regarding the MMSE
cores despite the fact that the test was only performed
nce. In addition, the MMSE was proposed to a relatively
mall sample but there were a sufﬁcient number of deaths
mong this subpopulation.
Although the relationship found in this study between CI
nd increased mortality in older people is well known, few
tudies have included such very elderly hospitalized partici-
ants, all with CVDs.
onclusion
n our relatively small cohort of very elderly hospitalized
atients with cardiovascular conditions, CI (as evaluated by
MSE) and malnutrition (as deﬁned by a low BMI and low
lasma albumin) are both predictors of all-cause mortality.
hese factors have a more important impact on mortal-
ty than traditional cardiovascular factors (such as arterial
ypertension, high cholesterol concentration or smoking).
s both variables are susceptible to modulation by pre-
entive maintenance of mental activities and adequate
utritional support programmes, the ability of their early
ystematic use to decrease mortality in the very elderly
hould be tested [24,26,34,35].
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